Updated On: 05 October, 2025 07:09 PM IST | Mumbai | mid-day online correspondent
The FDA has instructed all licence holders, retailers, hospitals, and the public to immediately stop the sale, distribution, or use of this batch and to report its possession to local Drug Control Authorities without delay

An official looks at bottles of the ‘Coldrif’ cough syrup after a raid by the Drug and Pharmaceuticals Department officials at Kataria Pharmaceuticals. Pic/PTI
The Food and Drugs Administration (FDA) in Maharashtra on Sunday issued an urgent alert following reports of child deaths in Madhya Pradesh and Rajasthan allegedly linked to a contaminated batch of Coldrif Syrup.
According to an official notification, the syrup, manufactured by Sresan Pharma in Tamil Nadu, is suspected to have been adulterated with Diethylene Glycol (DEG), a toxic chemical reportedly known to cause serious harm or even death if consumed.